AzTrials
AzTrials

Socket Shield TechniqueNCT07082634

Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone

A study testing Socket shield concept and immediate implant placement in people with Socket Shield Technique and Maxillary Esthetic Zone, run by Hams Hamed Abdelrahman at 1 site in Lebanon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Immediate implant placement in the esthetic zone is an approach that helps preserve soft and hard tissue architecture. However, post extraction bone resorption is still a significant challenge. Read more about this study

Who is it for?
Ages 18 to 40 years
What is being tested?
Socket shield concept and immediate implant placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteLebanon
Study dates
1 Sep 2025to 1 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with a non-restorable maxillary tooth in the aesthetic zone indicated for extraction and subsequent immediate implant placement.
  • Patients with extraction socket Type I.
  • A good standard of oral hygiene.

Who cannot join

  • Patients with extraction socket Type II or III, with defect in the buccal plate.
  • Absence of at least 2 mm bone apical to the extraction socket, necessary to obtain adequate primary stability for the implant assessed by pre-operative radiographic evaluation.
  • The presence of any local factor that may interfere with extraction as tooth ankylosis.
  • Patients with deciduous teeth.
  • Patients with bruxism
  • Heavy smokers.
Show all 10Show fewer
  • Systemic conditions that are considered as a contraindication for placement of implant or those that may interfere with wound healing and immunocompromised conditions and uncontrolled autoimmune diseases.
  • History of oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months.
  • Patients receiving radiotherapy or chemotheraphy.
  • Patient with active infection or chronic infection with severe bone loss.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lebanon1 site
  • Beirut Arab University

    Beirut, 11-5020

    Mohamed M Issa, BDS, +961 76 476 204, mohamadmarwanissa@gmail.com

    Mohamed Issa, BDS

Other trials in Lebanon

About this study

Official title: Evaluation of Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone (Clinical and Radiographic Study)

Immediate implant placement in the esthetic zone is an approach that helps preserve soft and hard tissue architecture. However, post extraction bone resorption is still a significant challenge. The socket shield technique (SST) has emerged as a promising way for preserving the buccal plate, potentially improving implant stability and reducing radiographic bone loss. The aim of the present study is to evaluate the clinical and radiographic outcomes of the socket shield technique in the maxillary esthetic zone by assessing implant stability, radiographic bone loss as well as esthetic outcome over a specified follow-up period.

Being tested
Socket shield concept and immediate implant placement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Socket shield concept and immediate implant placementProcedure or surgery

    Tooth Sectioning: The tooth will be sectioned mesiodistally using a fissure bur, preserving the buccal segment.

    Palatal fragment extraction: carefully after sectioning the tooth , the palatal fragment is luxated and extracted with the most important factor is taking care of the buccal part not to become loose , the extraction is done using a periotome to be minimally invasive and to preserve the bone from major damage.

    Shield Preparation: The buccal fragment is reduced to bone level using a round bur, a beveled edge is created using a diamond football bur, and the shield is thinned to maintain structural integrity.

    Implant Site Preparation: Sequential osteotomy performed under copious irrigation, ensuring primary stability.

    Implant Placement: A Megagen implant is inserted

Study groups in NCT07082634
Study groupRoleWhat they receive
Socket shield and immediate implantExperimentalNot described
Receives: Procedure: Socket shield concept and immediate implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain scores

    Pain will be evaluated, using visual analogue scale (VAS) as follows:

    (0-1= None, 2-4= Mild, 5-7= Moderate, 8-10= Severe) (Figure 1)

    Measured: baseline, 7, 14, and 21 days

  2. Change in implant stability

    The base line primary Implant Stability Quotient (ISQ) will be measured at the time of implant placement, while the secondary stability quotient will be measured after 6months during the prosthetic phase preparation.

    Measured: baseline and 6 months

Secondary outcomes (3)
  1. Change in post operative healing

    The wound healing will be assessed based on Landry Wound Healing Index. The Landry Index uses a numerical score based on the assessment of four given parameters (Erythema., Edema, Wound Margin Adaptation, and Presence of Exudate). Each parameter is given a score depending on its severity, and the total score determine an overall evaluation of wound healing

    Measured: baseline, 7, 14, and 21 days

  2. change in crestal alveolar process width

    The width of the crestal alveolar process will be assessed by determination of the dimensional changes of Bucco-palatal ridge in the 6 months' scan. Measurements will be taken from the preoperative records and compared to those taken in the 6 month ones.

    Measured: baseline and 6 months

  3. change in labial bone thickness

    the assessment of the thickness labial plate of bone in the scan performed after 6 months and comparing it with the preoperative CBCT scans.

    Measured: baseline and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion1 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
8 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07082634
Sponsor's protocol ID
2025-H-0176-D-M-0796
Status last verified
Jul 2025
First submitted
15 Jul 2025
Last updated
24 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Socket shield concept and immediate implant placement in people with Socket Shield Technique and Maxillary Esthetic Zone, run by Hams Hamed Abdelrahman at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohamed M Issa, BDS (+961 76 476 204, mohamadmarwanissa@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain scores (time frame: baseline, 7, 14, and 21 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in